Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
An NF-κB/IRF1 axis programs cDC1 to drive antitumor immunity II
PubMed Similar studies SRA Run Selector
An NF-κB/IRF1 axis programs cDC1 to drive antitumor immunity
Effect of Flt3L and DNGR-1 on the biology of tumor-infiltrating type 1 dendritic cells
PubMed Full text in PMC Similar studies SRA Run Selector
Monocyte-derived DC Expression Data from Advanced Staged Melanoma Patients
PubMed Full text in PMC Similar studies Analyze with GEO2R
STAT3 Inhibits Autocrine Interferon Signaling in Type I Conventional Dendritic Cells
Nanostring analysis of MC38 tumors in PBS and hetIL-15-treated mice
Single cell analysis informs efficient reprogramming of human somatic cells to dendritic cells type 1
PubMed Full text in PMC Similar studies
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
RNA sequencing of CD103+ cDC1 from melanoma tumors
PubMed Similar studies
RNA sequencing of human peripheral blood cDC1 treated with PGE2
PubMed Similar studies Analyze with GEO2R
RNA sequencing of murine bone marrow cell-derived cDC1 treated with PGE2
Expression data from unstimulated vs. anti-CD40 stimulated cDC1 from WT mouse skin draining lymph node
Opposing tumor cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in anti-tumor immunity
ISR8 / IRF1-AS1 is relevant for IFNα and NF-κB responses
Expression data from melanoma cell lines
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 2]
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [scRNA-Seq 1]
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [ATAC-Seq]
SLC38A2 and glutamine signaling in cDC1 dictate anti-tumor immunity [array]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on